Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 18;16(5):762.
doi: 10.3390/ph16050762.

Honey-Related Treatment Strategies in Dry Eye Disease

Affiliations
Review

Honey-Related Treatment Strategies in Dry Eye Disease

Julia Prinz et al. Pharmaceuticals (Basel). .

Abstract

This systematic review and meta-analysis investigated whether honey-related treatment strategies improve the signs and symptoms of patients with dry eye disease (DED). In March 2023, the following databases were accessed for clinical trials investigating the efficacy of honey-related treatment strategies in DED: PubMed, Web of Science, Google Scholar, and EMBASE. The following data were extracted at baseline and at the last follow-up: Ocular Surface Disease Index, tear breakup time, Schirmer I test, and corneal staining. Data from 323 patients were retrieved (53.3% female, mean age 40.6 ± 18.1 years). The mean follow-up was 7.0 ± 4.2 weeks. All the endpoints of interest significantly improved from baseline to the last follow-up: tear breakup time (p = 0.01), Ocular Surface Disease Index (p < 0.0001), Schirmer I test (p = 0.0001), and corneal staining (p < 0.0001). No difference was found in tear breakup time (p = 0.3), Ocular Surface Disease Index (p = 0.4), Schirmer I test (p = 0.3), and corneal staining (p = 0.3) between the honey-related treatment strategies and the control groups. According to our main results, honey-related treatment strategies are effective and feasible to improve symptoms and signs of DED.

Keywords: Manuka; Royal Jelly; dry eye disease; honey; keratoconjunctivitis sicca; xerophthalmus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow chart of the literature search.
Figure 2
Figure 2
Methodological quality assessment.
Figure 3
Figure 3
Funnel plot to evaluate the risk of publication bias.
Figure 4
Figure 4
Results of the meta-analysis [27,29,36,38].
Figure 4
Figure 4
Results of the meta-analysis [27,29,36,38].

Similar articles

Cited by

References

    1. Craig J.P., Nelson J.D., Azar D.T., Belmonte C., Bron A.J., Chauhan S.K., de Paiva C.S., Gomes J.A.P., Hammitt K.M., Jones L., et al. TFOS DEWS II Report Executive Summary. Ocul. Surf. 2017;15:802–812. doi: 10.1016/j.jtos.2017.08.003. - DOI - PubMed
    1. Craig J.P., Nichols K.K., Akpek E.K., Caffery B., Dua H.S., Joo C.K., Liu Z., Nelson J.D., Nichols J.J., Tsubota K., et al. TFOS DEWS II Definition and Classification Report. Ocul. Surf. 2017;15:276–283. doi: 10.1016/j.jtos.2017.05.008. - DOI - PubMed
    1. Uchino M., Dogru M., Yagi Y., Goto E., Tomita M., Kon T., Saiki M., Matsumoto Y., Uchino Y., Yokoi N., et al. The features of dry eye disease in a Japanese elderly population. Optom. Vis. Sci. 2006;83:797–802. doi: 10.1097/01.opx.0000232814.39651.fa. - DOI - PubMed
    1. Nagino K., Sung J., Oyama G., Hayano M., Hattori N., Okumura Y., Fujio K., Akasaki Y., Huang T., Midorikawa-Inomata A., et al. Prevalence and characteristics of dry eye disease in Parkinson’s disease: A systematic review and meta-analysis. Sci. Rep. 2022;12:18348. doi: 10.1038/s41598-022-22037-y. - DOI - PMC - PubMed
    1. Hazra D., Yotsukura E., Torii H., Mori K., Maruyama T., Ogawa M., Hanyuda A., Tsubota K., Kurihara T., Negishi K. Relation between dry eye and myopia based on tear film breakup time, higher order aberration, choroidal thickness, and axial length. Sci. Rep. 2022;12:10891. doi: 10.1038/s41598-022-15023-x. - DOI - PMC - PubMed

LinkOut - more resources